Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 0.01
NIMU's Cash to Debt is ranked lower than
99% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. NIMU: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
NIMU' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 1.2 Max: No Debt
Current: 0.01
Equity to Asset -5.16
NIMU's Equity to Asset is ranked lower than
99% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. NIMU: -5.16 )
Ranked among companies with meaningful Equity to Asset only.
NIMU' s Equity to Asset Range Over the Past 10 Years
Min: -7  Med: 0.34 Max: 1
Current: -5.16
-7
1
F-Score: 3
Z-Score: -82.18
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -1139.13
NIMU's Operating margin (%) is ranked lower than
92% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. NIMU: -1139.13 )
Ranked among companies with meaningful Operating margin (%) only.
NIMU' s Operating margin (%) Range Over the Past 10 Years
Min: -2407.69  Med: -334.98 Max: -159.82
Current: -1139.13
-2407.69
-159.82
Net-margin (%) -1843.48
NIMU's Net-margin (%) is ranked lower than
95% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.24 vs. NIMU: -1843.48 )
Ranked among companies with meaningful Net-margin (%) only.
NIMU' s Net-margin (%) Range Over the Past 10 Years
Min: -3407.69  Med: -323.81 Max: -179.77
Current: -1843.48
-3407.69
-179.77
ROA (%) -81.63
NIMU's ROA (%) is ranked lower than
87% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. NIMU: -81.63 )
Ranked among companies with meaningful ROA (%) only.
NIMU' s ROA (%) Range Over the Past 10 Years
Min: -200.33  Med: -85.63 Max: -66.32
Current: -81.63
-200.33
-66.32
ROC (Joel Greenblatt) (%) -131000.00
NIMU's ROC (Joel Greenblatt) (%) is ranked lower than
99% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 4.17 vs. NIMU: -131000.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NIMU' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -27500  Med: -1537.82 Max: -159.32
Current: -131000
-27500
-159.32
Revenue Growth (3Y)(%) -100.00
NIMU's Revenue Growth (3Y)(%) is ranked lower than
97% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. NIMU: -100.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NIMU' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -100  Med: -22.3 Max: 47
Current: -100
-100
47
EBITDA Growth (3Y)(%) -20.60
NIMU's EBITDA Growth (3Y)(%) is ranked lower than
83% of the 192 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. NIMU: -20.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NIMU' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -26.3 Max: 35.7
Current: -20.6
0
35.7
» NIMU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with NIMU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:DHRM, AMEX:HRT, OTCPK:ABMT, NAS:VSCP, OTCPK:PBIO, OTCPK:PETV, OTCPK:IGNG, NAS:MDGS, AMEX:XTNT, OTCPK:AROSF, OTCPK:SMLR, OTCBB:NAOV, NAS:SSH, OTCPK:GIDYL, NAS:DYNT, OTCPK:CRVW, OTCPK:ZYXI, OTCPK:AIRW, OTCPK:ACXA, NAS:PHMD » details
Non-Invasive Monitoring Systems together with its subsidiaries is engaged in the research, development, manufacturing, and marketing of non-invasive, motorized, and whole body periodic acceleration platforms in the United States.

Non-Invasive Monitoring Systems Inc was incorporated under the laws of the State of Florida on July 16, 1980. The Company, together with its subsidiaries, engages in the research, development, manufacture, and marketing of non-invasive, motorized, and whole body periodic acceleration platforms in the United States. The Company provides Exer-Rest line of acceleration therapeutic platforms that include the Exer-Rest AT3800 and the Exer-Rest AT4700; and LifeShirt, a wearable physiological computer that incorporates transducers, electrodes, and sensors into a sleeveless garment. It also has licenses for its non-invasive diagnostic monitoring devices and related software products. The Company markets the Exer-Rest platforms to hospitals, cardiac rehabilitation clinics, chiropractic and physical therapy centers, senior living communities, and other healthcare providers, as well as to their patients, professional athletes, and other individuals.

Ratios

vs
industry
vs
history
EV-to-EBIT -45.23
NIMU's EV-to-EBIT is ranked lower than
99.99% of the 164 Companies
in the Global Medical Devices industry.

( Industry Median: 22.51 vs. NIMU: -45.23 )
Ranked among companies with meaningful EV-to-EBIT only.
NIMU' s EV-to-EBIT Range Over the Past 10 Years
Min: -110.1  Med: -33.3 Max: -10
Current: -45.23
-110.1
-10
EV-to-EBITDA -45.41
NIMU's EV-to-EBITDA is ranked lower than
99.99% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 16.88 vs. NIMU: -45.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
NIMU' s EV-to-EBITDA Range Over the Past 10 Years
Min: -111.1  Med: -35.9 Max: -10.8
Current: -45.41
-111.1
-10.8
Current Ratio 0.02
NIMU's Current Ratio is ranked lower than
99% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. NIMU: 0.02 )
Ranked among companies with meaningful Current Ratio only.
NIMU' s Current Ratio Range Over the Past 10 Years
Min: 0.02  Med: 0.97 Max: 9.15
Current: 0.02
0.02
9.15
Quick Ratio 0.02
NIMU's Quick Ratio is ranked lower than
99% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. NIMU: 0.02 )
Ranked among companies with meaningful Quick Ratio only.
NIMU' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.53 Max: 8.2
Current: 0.02
0.01
8.2
Days Inventory 2.00
NIMU's Days Inventory is ranked higher than
99% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 132.35 vs. NIMU: 2.00 )
Ranked among companies with meaningful Days Inventory only.
NIMU' s Days Inventory Range Over the Past 10 Years
Min: 119.13  Med: 1518.95 Max: 27892.08
Current: 2
119.13
27892.08
Days Sales Outstanding 15.87
NIMU's Days Sales Outstanding is ranked higher than
95% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 68.07 vs. NIMU: 15.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
NIMU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.35  Med: 37.01 Max: 124.82
Current: 15.87
3.35
124.82

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -4.70
NIMU's 3-Year Average Share Buyback Ratio is ranked lower than
53% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. NIMU: -4.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
NIMU' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -29.9  Med: -11.6 Max: -0.3
Current: -4.7
-29.9
-0.3

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) -2.20
NIMU's Earnings Yield (Greenblatt) (%) is ranked lower than
58% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. NIMU: -2.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
NIMU' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -2.31  Med: 1 Max: 1.1
Current: -2.2
-2.31
1.1

More Statistics

Revenue (TTM) (Mil) $0.02
EPS (TTM) $ -0.01
Beta2.63
Short Percentage of Float0.00%
52-Week Range $0.10 - 0.20
Shares Outstanding (Mil)79.01

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)